Skip to main content
SpringerLink
Log in

News from the 40th European Symposium on Clinical Pharmacy; 18–21 October 2011; Dublin

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Normand C. Doing more with less [evening lecture]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  2. Mulder H. Can pharmacogenomics deliver better outcomes? [plenary lecture 1.1]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  3. Swen JJ, Nijenhuis M, de Boer A, et al. Pharmacogenetics: from bench to byte—an update of guidelines. Clin Pharmacol Ther 2011 May; 89(5): 662–73

    Article  PubMed  CAS  Google Scholar 

  4. Tomlin S. Clinical pharmacy across the life span [plenary lecture 1.2]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  5. Henman M. The personal and professional challenge of intellectual disability [plenary lecture 1.3]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  6. Deb S, Kwok H, Bertelli M, et al. International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities. World Psychiatry 2009 Oct; 8(3): 181–6

    PubMed  Google Scholar 

  7. McElnay J. Remote monitoring: extending pharmaceutical care [plenary lecture 2.1]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  8. Provenzani A. Supporting clinical interventions and performance managment [plenary lecture 2.2]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  9. Seger AC. Decision support systems: drug-drug interaction software [plenary lecture 2.3]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  10. McKone E. In-patient care: cystic fibrosis [plenary lecture 3.1]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  11. Gregan P. Primary care: palliative care [plenary lecture 3.2]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  12. Van Loon H. Adherence of outpatients with schizophrenia and schizophrenic disorder using long-acting antispychotics with supportive outreaching: a matched case control study and a plea for more LAAP’s? [plenary lecture 3.3]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  13. Dalleur O, Spinewine A, Henrard S, et al. Prescribing omissions according to START and related hospital admissions in frail older patients [abstract no. PC-020]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

  14. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): consensus validation. Int J Clin Pharmacol Ther 2008; 46(2): 72–83

    PubMed  CAS  Google Scholar 

  15. Peloso C, Fouché C, Baylatry M-T, et al. Clinical utility of intraperitoneal chemotherapy in the management of patients with advanced ovarian cancer [abstract no. IDMD-002]. 40th European Symposium on Clinical Pharmacy; 2011 Oct 18–21; Dublin

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

News from the 40th European Symposium on Clinical Pharmacy; 18–21 October 2011; Dublin. Drugs Ther Perspect 28, 22–26 (2012). https://doi.org/10.2165/11606300-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11606300-000000000-00000

Search

Navigation